RCP Venture Capital

04 · For founders

Stuck between data and dollars? That’s where we start.

We back life science companies at pivotal moments — when the next milestone needs capital outside the scope of larger funds, and commercial expertise at a time when building a full commercial team may be premature.

What we look for

Science, leadership, and a milestone in sight.

01

Strong leadership

High-value assets led by strong leadership teams — the combination we look for first.

02

Breakthroughs in areas of high unmet need

Breakthrough therapies or interventions — across therapeutics, diagnostics, medical devices and health tech.

03

A clear near-term milestone

A defined clinical or commercial goal that targeted capital can unlock — and a view of the value inflection it creates.

04

A core focus on data

Investors are looking for proof of concept. Companies that lead with the thoroughness of their data stand out.

Disciplined non-investment criteria

What we don’t invest in.

Commercial readiness, not science alone, determines outcomes. We pass when we see any of these — and we’ll tell you why, so you can address it early.

  • Regulatory path ambiguity

    Programs without a clear, credible route through FDA or other regulators.

  • Reimbursement misalignment

    Products whose pricing and payer story don’t yet hold together.

  • Weak organizational readiness to advance

    Teams not yet equipped to execute the next stage of development.

  • Capital intensity without value inflection

    Large capital needs with no near-term milestone that meaningfully changes value.

What we bring

Partnership beyond capital.

“Our decisions are based on the benefit, the thoroughness of the data and the market opportunity. And that’s what guides us.”
Christina Ansted · EisnerAmper Engaging Alternatives podcast, Oct 2024

01

Incremental, milestone-driven capital sized to near-term clinical development objectives

02

Hands-on guidance from active partners who work alongside management teams

03

Access to Rapid Commercialization Partners’ operational leadership and commercialization expertise

04

Relationships with larger venture capital and private equity investors for follow-on financing

Commercialization support spans

Commercial StrategyMarket AccessMedical AffairsRegulatory

See the integrated platform →

Our process

What working with us looks like.

Five steps from first conversation to active partnership. Expect partner-level attention from the start — and a commercial lens on every stage.

  1. 01

    Opportunity identification

    Companies come to us through our operator, advisor, and partner networks — including RCP’s commercialization work.

  2. 02

    Initial validation & prioritization

    A partner-level review of clinical inflection, commercial readiness, capital efficiency, and strategic fit.

  3. 03

    Diligence & investment committee

    Integrated clinical, regulatory, reimbursement, and commercialization diligence, culminating in a formal investment committee decision.

  4. 04

    Terms & structuring

    Negotiation of terms, syndicate formation, and capital sized to your next milestones.

  5. 05

    Value creation after investment

    Ongoing strategic guidance across clinical positioning, market access, and commercial execution.

Before you reach out

Answer the hard questions early.

Competition for early-stage funding remains intense, and investors have pulled back from purely conceptual stories toward proof of concept. The companies that stand out keep a core focus on data and stay capital efficient.
They also have answers to difficult questions earlier than is typical in the industry — around things like pricing and the path to reimbursement — which can drive real value in conversations with investors.
Adapted from Christina Ansted’s remarks on the EisnerAmper Engaging Alternatives podcast.
Introduce your company on LinkedIn

Founders · Co-investors · LPs

Advancing through the clinic? Let’s talk.

The quickest way to reach the partners is LinkedIn. Send a note about your company, your next milestone, and what it would unlock.
Message RCP VC on LinkedIn
For founders

Submit your company.

Building in therapeutics, diagnostics, or life-science tools? Share a short overview and your deck, and our team will review it and follow up if there’s a fit.

What happens next
  1. 01We review every submission.
  2. 02If there’s a fit, we’ll reach out to schedule an intro call.
  3. 03Diligence with our operating network.